Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy.

High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: incidence and implications for patient care and surveillance. World J Urol (2009) 0.85

Pathologic results of radical prostatectomies in patients with simultaneous atypical small acinar proliferation and prostate cancer. Korean J Urol (2010) 0.81

Predictive factors of prostate cancer at repeat biopsy in patients with an initial diagnosis of atypical small acinar proliferation of the prostate. Korean J Urol (2010) 0.79

What is the ideal core number for ultrasound-guided prostate biopsy? Korean J Urol (2014) 0.79

Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy. J Urol (2003) 0.75

Multiple cores of high grade prostatic intraepithelial neoplasia and any core of atypia on first biopsy are significant predictor for cancer detection at a repeat biopsy. Korean J Urol (2015) 0.75

An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell (2011) 2.78

Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat Med (2002) 2.23

Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis. Mod Pathol (2006) 1.87

Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer (2004) 1.85

MicroRNA profiling of human kidney cancer subtypes. Int J Oncol (2009) 1.68

Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Res (2007) 1.66

Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS One (2008) 1.64

Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns. Histopathology (2010) 1.61

Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations. Arch Pathol Lab Med (2006) 1.52

Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology. Am J Surg Pathol (2008) 1.49

Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res (2004) 1.47

Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J Immunol (2002) 1.45

Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression. Urology (2006) 1.44

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene (2003) 1.42

The E2F3-Oncomir-1 axis is activated in Wilms' tumor. Cancer Res (2008) 1.33

Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Hum Pathol (2009) 1.31

Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma. Am J Surg Pathol (2007) 1.22

Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol (2005) 1.21

P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol (2002) 1.21

Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol (2005) 1.20

MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J Natl Cancer Inst (2009) 1.20

Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol (2005) 1.19

Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma. Am J Surg Pathol (2004) 1.17

Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res (2009) 1.16

Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Am J Surg Pathol (2009) 1.15

Glypican 3: a novel marker in testicular germ cell tumors. Am J Surg Pathol (2006) 1.14

A working group classification of focal prostate atrophy lesions. Am J Surg Pathol (2006) 1.13

Predictors of response to targeted therapy in renal cell carcinoma. Arch Pathol Lab Med (2012) 1.10

Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res (2007) 1.10

Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer (2010) 1.08

Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer. BMC Cancer (2006) 1.08

C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum Pathol (2005) 1.08

Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Clin Cancer Res (2007) 1.08

TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence. PLoS One (2011) 1.08

Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S). Am J Clin Pathol (2004) 1.08

Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer. Prostate (2005) 1.07

Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res (2002) 1.06

Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions. Arch Pathol Lab Med (2008) 1.06

Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med Genomics (2010) 1.06

Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle. Mol Cancer Ther (2006) 1.05

Renal medullary carcinoma and ABL gene amplification. J Urol (2005) 1.05

Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol (2004) 1.05

Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas. Ann Clin Lab Sci (2006) 1.04

Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder. BMC Med Genomics (2010) 1.03

Minor modifications in apical dissection of radical retropubic prostatectomy in patients with clinical stage T2 prostate cancer reduce positive surgical margin incidence. Urology (2004) 1.02

Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol (2004) 1.00

Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment. Cancer Biol Ther (2008) 0.99

Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma. Hum Pathol (2006) 0.98

Signet-ring cell carcinoma of the gallbladder with skin metastases. Australas J Dermatol (2007) 0.98

Expression analysis of putative stem cell markers in human benign and malignant prostate. Prostate (2011) 0.96

Expression of S-100 protein in renal cell neoplasms. Hum Pathol (2006) 0.95

Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma. J Urol (2008) 0.95

Absence of Y chromosome in human placental site trophoblastic tumor. Mod Pathol (2007) 0.94

Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma. Gynecol Oncol (2008) 0.92

c-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Mod Pathol (2005) 0.92

Computer-aided identification of prostatic adenocarcinoma: Segmentation of glandular structures. J Pathol Inform (2011) 0.92

Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review. Anal Quant Cytol Histol (2006) 0.91

Multiple clustered dermatofibroma: case report and review of the literature. J Cutan Pathol (2009) 0.91

Differential diagnosis of renal tumors with clear cytoplasm: clinical relevance of renal tumor subclassification in the era of targeted therapies and personalized medicine. Arch Pathol Lab Med (2013) 0.91

Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy. Am J Clin Pathol (2008) 0.91

Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance. Arch Pathol Lab Med (2013) 0.91

The expression and function of androgen receptor coactivator p44 and protein arginine methyltransferase 5 in the developing testis and testicular tumors. J Urol (2007) 0.91

The methodology used to measure differential gene expression affects the outcome. J Biomol Tech (2007) 0.90

Histopathologic and immunohistochemical characterization of rash to human epidermal growth factor receptor 1 (HER1) and HER1/2 inhibitors in cancer patients. Clin Cancer Res (2010) 0.90

Recurrent giant cell carcinoma of the bladder. J Urol (2002) 0.90

Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases. Hum Pathol (2007) 0.90

p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion. Int J Cancer (2010) 0.89

Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Anal Quant Cytol Histol (2006) 0.88

Rapid intraoperative immunohistochemical evaluation of sentinel lymph nodes for metastatic breast carcinoma. Appl Immunohistochem Mol Morphol (2006) 0.87

High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins. J Hematol Oncol (2014) 0.87

Computer-aided detection of prostate cancer on tissue sections. Appl Immunohistochem Mol Morphol (2009) 0.87

Expression of glypican 3 in ovarian and extragonadal germ cell tumors. Am J Clin Pathol (2008) 0.87

Role of monocyte-lineage cells in prostate cancer cell invasion and tissue factor expression. Prostate (2010) 0.86

Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma. Am J Clin Pathol (2005) 0.85

Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. Am J Surg Pathol (2004) 0.85

P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens. Am J Clin Pathol (2004) 0.84

The desmosomal armadillo protein plakoglobin regulates prostate cancer cell adhesion and motility through vitronectin-dependent Src signaling. PLoS One (2012) 0.84

Vimentin reactivity in renal oncocytoma: immunohistochemical study of 234 cases. Arch Pathol Lab Med (2007) 0.84

Expression of glypican 3 in placental site trophoblastic tumor. Diagn Pathol (2010) 0.83

Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol (2006) 0.83

Altered expression of members of the IGF-axis in clear cell renal cell carcinoma. Int J Oncol (2005) 0.83

Immunohistochemical detection of the von Hippel-Lindau gene product (pVHL) in human tissues and tumors: a useful marker for metastatic renal cell carcinoma and clear cell carcinoma of the ovary and uterus. Am J Clin Pathol (2008) 0.83

Pediatric renal cell carcinoma as second malignancy: reports of two cases and a review of the literature. Can J Urol (2007) 0.82

Gene expression profiling in kidney cancer: combining differential expression and chromosomal and pathway analyses. Clin Genitourin Cancer (2006) 0.81

A unique renal cell carcinoma with features of papillary renal cell carcinoma and thyroid-like carcinoma: a morphological, immunohistochemical and genetic study. Histopathology (2010) 0.81

Alpha-methylacyl coenzyme A racemase as a marker for prostate cancer. JAMA (2002) 0.81

Immunohistochemical detection of P504S in primary and metastatic renal cell carcinomas. Appl Immunohistochem Mol Morphol (2004) 0.81

Prevalence of high-grade prostatic intraepithelial neoplasia and its relationship to serum prostate specific antigen. Int Braz J Urol (2005) 0.81

Angiosarcoma masquerading as embryonal carcinoma in the metastasis from a mature testicular teratoma. Arch Pathol Lab Med (2003) 0.80

Protein markers of malignant potential in penile and vulvar lichen sclerosus. J Urol (2013) 0.79

Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathy. Nat Rev Urol (2010) 0.79

FXYD3: A Promising Biomarker for Urothelial Carcinoma. Biomark Insights (2011) 0.79

Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation. Am J Surg Pathol (2015) 0.78

Pathogenesis and significance of collagenous micronodules of the prostate. Appl Immunohistochem Mol Morphol (2003) 0.78

Expression of carbonic anhydrase IX in genitourinary and adrenal tumours. Histopathology (2011) 0.78

P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Anticancer Res (2005) 0.78

Glypican 3 overexpression in primary and metastatic Wilms tumors. Virchows Arch (2014) 0.78

Urothelial-type adenocarcinoma of the prostate mimicking metastatic colorectal adenocarcinoma. Int Braz J Urol (2007) 0.77

Clinical utility of delayed-contrast computed tomography for tissue characterization of cardiac thrombus. J Cardiovasc Comput Tomogr (2007) 0.77

Altered expression of alpha-methylacyl-coenzyme A racemase in prostatic adenocarcinoma following hormone therapy. Am J Clin Pathol (2005) 0.77